Maximum quantity allowed is 999
CAS RN: 226721-96-6 | Product Number: L0252
Loxoprofen Sodium Salt Dihydrate
Purity: >98.0%(T)(HPLC)
- Sodium 2-[4-[(2-Oxocyclopentyl)methyl]phenyl]propionate Dihydrate
- 2-[4-[(2-Oxocyclopentyl)methyl]phenyl]propionic Acid Sodium Salt Dihydrate
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 5G |
$78.00
|
5 | 0 | Contact Us | |
| 25G |
$259.00
|
5 | 20 | Contact Us |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
| Product Number | L0252 |
Purity / Analysis Method
|
>98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__1__5H__1__7NaO__3·2H__2O = 304.32 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 226721-96-6 |
Related CAS RN
|
80382-23-6&68767-14-6 |
| Reaxys Registry Number | 5686164 |
| PubChem Substance ID | 253659596 |
| Merck Index (14) | 5589 |
| MDL Number | MFCD01745788 |
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Ion exchange titration) | min. 98.0 %(calcd.on anh.substance) |
| Water | 11.0 to 13.0 % |
| NMR | confirm to structure |
| Melting Point | 198 °C(dec.) |
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H301 : Toxic if swallowed. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
| RTECS# | CY1678845 |
| UN Number | UN2811 |
| Class | 6.1 |
| Packing Group | III |
| H.S.code* | 2918.30-000 |
References
- Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells
- Inhibition of prostaglandin production in the inflammatory tissue by loxoprofen-sodium, an anti-inflammatory prodrug
- Inhibition of prostaglandin synthesis by sodium 2-[4-(2-oxocyclopentylmethyl)phenyl] propionate dihydrate (CS-600), a new antiinflammatory drug, and its active metabolite in vitro and in vivo
- Purification and some properties of ketone reductase forming an active metabolite of sodium 2-[4-(2-oxocyclopentylmethyl)phenyl]propionate dihydrate (loxoprofen sodium), a new antiinflammatory agent, in rabbit liver cytosol
- Identification of degradation products in loxoprofen sodium adhesive tapes by liquid chromatography-mass spectrometry and dynamic pressurized liquid extraction-solid-phase extraction coupled to liquid chromatography-nuclear magnetic resonance spectroscopy
Documents
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
The requested SDS is not available.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
The requested specifications are not available.
C of A & Other Certificates
Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
Please check that the lot number you have entered is correct. It is 7 alphanumeric characters. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.